Jianhui Ma

Company: Zentalis Pharmaceuticals

Job title: Associate Director

Seminars:

Combining Azenosertib with Antibody-Drug Conjugates Demonstrates Synergistic Antitumor Effects 2:20 pm

Exploring the synergistic antitumor effects of combining azenosertib with TOP1 inhibitors or ADCs with TOP1 inhibitor/microtubule inhibitor payloads in various cancer models Discussing the enhanced therapeutic efficacy observed when azenosertib is combined with trastuzumab deruxtecan (T-Dxd) in HER2+ breast cancer models, analyzing the potential to improve responses to TOP1 inhibitor-based ADCs in HER2+ ovarian and…Read more

day: Day One